About Dr. Dinesh Bhurani
Dr. Dinesh Bhurani is a distinguished Senior Consultant Hemato-Oncologist and Bone Marrow Transplant Specialist based in New Delhi, widely recognised as a leading Hematologist specialist in New Delhi, India for haematological malignancies, bone marrow transplant, CAR-T cell therapy, and stem cell transplantation.
- 23+ years of clinical and research experience in haematology
- MBBS from Jiwaji University, Gwalior, MP, India, 1993
- MD from Pt. Ravishankar Shukla University, Raipur, MP, India, 1997
- DM in Clinical Haematology from Christian Medical College (CMC), Vellore, India, 2001 (First DM Hematology graduate in India)
- FRCPA — Fellow of the Royal College of Pathologists of Australia, 2004
- Currently Director / Senior Consultant & Chief of Hemato-Oncology Services and Bone Marrow Transplant Unit at Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), Rohini, New Delhi (since 2007)
- Performed 1,500+ stem cell transplants at RGCIRC
- Performed first haplo transplant of North India
- Conducted highest number of CAR-T procedures in Northern India
Qualifications & Credentials
Medical Degrees
- MBBS — Jiwaji University, Gwalior, MP, India, 1993
- MD — Pt. Ravishankar Shukla University, Raipur, MP, India, 1997
- DM in Clinical Haematology — Christian Medical College (CMC) & Hospital, Vellore (Tamil Nadu Dr. M.G.R. Medical University), India, 2001 (First DM Hematology graduate in India)
Fellowships & Special Training
- FRCPA — Fellow of the Royal College of Pathologists of Australia, 2004
- Bone Marrow Transplant & Hematology Training — Royal Melbourne Hospital, Australia (1 year, Feb 2002 – Feb 2003)
- Bone Marrow Transplant & Hematology Training — Austin Hospital, Melbourne, Australia (1 year)
- Hematology Training — West Sydney Area Health Service, Australia (~18 months, 2003–2005)
- The Eddie Hirst Memorial Prize — Royal College of Pathologists, Australia (Pathological Sciences)
- Specialised training in Allogeneic Stem Cell Transplant
- Specialised training in Autologous Stem Cell Transplant
- Specialised training in Matched Unrelated Donor (MUD) Stem Cell Transplant
- Specialised training in Haplo (Half-Matched) Stem Cell Transplant
- Specialised training in CAR-T Cell Therapy
- Successful participation in CME "Lymphoma B-Cell" — University of Nebraska Medical Center, ASCME
Certifications & Accreditations
- Delhi Medical Council — Registered
- National Medical Commission / Medical Council of India Registration
- Board-Certified Specialist — Clinical Haematology (DM, CMC Vellore, 2001)
- Fellow — Royal College of Pathologists of Australia (FRCPA), 2004
Areas of Expertise
Major Conditions Treated
- Acute Myeloid Leukaemia (AML)
- Acute Lymphoblastic Leukaemia (ALL)
- Chronic Myeloid Leukaemia (CML)
- Lymphoma (Hodgkin and Non-Hodgkin)
- Multiple Myeloma
- Myelodysplastic Syndrome (MDS)
- Aplastic Anaemia
- Thalassaemia Major
- Sickle Cell Disease
- Chronic Lymphocytic Leukaemia (CLL)
- Von Willebrand Disease
- Bleeding Disorders & Coagulopathies
- Bone Marrow Failure Syndromes
- Myeloproliferative Neoplasms
- Cold Agglutinin Disease
Sub-specialties
- Bone Marrow / Stem Cell Transplantation: 1,500+ stem cell transplants performed at RGCIRC — establishes him as a trusted hematologist specialist in New Delhi, India.
- Allogeneic Stem Cell Transplant: Specialist in matched sibling donor transplant.
- Matched Unrelated Donor (MUD) Stem Cell Transplant: Specialist in MUD transplant.
- Haplo (Half-Matched) Stem Cell Transplant: Performed first haplo transplant of North India — for international patients seeking best bone marrow transplant in India.
- CAR-T Cell Therapy: Conducted highest number of CAR-T procedures in Northern India.
- Thalassemia & Aplastic Anaemia Transplants: Specialist in transplants for non-malignant haematological disorders.
Advanced Procedures & Treatments
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Matched Unrelated Donor (MUD) Stem Cell Transplant
- Haplo (Half-Matched) Stem Cell Transplant
- CAR-T Cell Therapy
- Bone Marrow Aspiration and Biopsy
- CD138 Immunostaining for Plasma Cell Disorders
- Bone Marrow Trephine Specimen Analysis
- Acute Leukaemia Chemotherapy (Induction, Consolidation, Maintenance)
- Lymphoma Chemotherapy & Targeted Therapy
- Multiple Myeloma Chemotherapy & Targeted Therapy
- Imatinib and TKI Therapy for CML
- Azacitidine for MDS
- Blood Transfusion & Component Therapy
- Plasmapheresis
- Lymphatic Drainage
- Immunotherapy
List of Disease and Treatment for which Dr. Dinesh Bhurani can be consulted
Professional Experience
Current Affiliation
- Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), Sir Chotu Ram Marg, Sector-5, Rohini, New Delhi – 110085 — Director / Senior Consultant & Chief of Hemato-Oncology Services and Bone Marrow Transplant Unit, Since 2007
- Bhurani Clinic, Rohini, New Delhi — Private Practice, Present
Past Affiliations
- Sir Ganga Ram Hospital, New Delhi — Associate Consultant, Chairman (August 2005 – April 2006)
- West Sydney Area Health Service, Australia — Hematology (~18 months, 2003–2005)
- Austin Hospital, Melbourne, Australia — Hematology & BMT (~1 year)
- Royal Melbourne Hospital, Melbourne, Australia — Hematology & BMT (~1 year, Feb 2002 – Feb 2003)
- Christian Medical College (CMC) Vellore — Consultant (April 2001 – February 2002)
- RGCIRC — Director, Department of Haematology & Bone Marrow Transplant (2008–2016, prior to current Senior Consultant role)
Academic & Research Roles
- Director / Senior Consultant — Department of Haematology & Bone Marrow Transplant, RGCIRC, New Delhi
- Chief — Hemato-Oncology Services, RGCIRC
- Chief — Bone Marrow Transplant Unit, RGCIRC
- First DM Hematology graduate in India — heading the department since 2007
- Member — Indian Society of Hematology and Blood Transfusion
- Member — Pediatric Hematology-Oncology Chapter of Indian Academy of Pediatrics
- Member — Royal College of Pathologists of Australia (RCPA)
- Principal Investigator — Multiple clinical trials for haematological malignancies (lymphoma, myeloma, CLL)
- Co-Investigator — Many Medical Oncology trials since 2007
- Supervisor — DNB students; Co-supervisor for PhD and MSc students
- Author — Multiple national and international peer-reviewed publications
- ICMR Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade) contributor
Key Achievements
- 23+ years of clinical and research experience in haematology
- First DM Hematology graduate in India (CMC Vellore, 2001)
- Currently Director / Senior Consultant & Chief of Hemato-Oncology Services at Rajiv Gandhi Cancer Institute & Research Centre (since 2007, 17+ years)
- 1,500+ stem cell transplants performed at RGCIRC
- Performed first haplo transplant of North India
- Conducted highest number of CAR-T procedures in Northern India
- FRCPA — Royal College of Pathologists of Australia, 2004
- The Eddie Hirst Memorial Prize for Pathological Sciences, Royal College of Pathologists, Australia
- 3+ years of training in Australia (Royal Melbourne Hospital, Austin Hospital, West Sydney)
- Multiple peer-reviewed publications in international and national journals
- Pioneer in haemato-oncology — credited with starting multiple pioneer works in the field at global level
Awards & Recognitions
National & International Awards
- The Eddie Hirst Memorial Prize for Pathological Sciences — Royal College of Pathologists, Australia
- FRCPA — Fellow of the Royal College of Pathologists of Australia, 2004
- First DM Hematology graduate in India — CMC Vellore, 2001
Professional Memberships
- Indian Society of Hematology and Blood Transfusion — Active Member
- Pediatric Hematology-Oncology Chapter of Indian Academy of Pediatrics — Member
- Royal College of Pathologists of Australia (RCPA) — Member & Fellow
- Delhi Medical Council — Registered
- National Medical Commission / Medical Council of India — Registered
Research & Publications
Published Papers (Selected)
- Khan MA, Bhurani D, Hoda U, Sehar N, Agarwal N. "Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy." Arquivos de Neuro-psiquiatria, October 2022.
- Kapoor J, Shaikh MR, Tejwani N, Singh R, Khushoo V, Halder R, Mehta P, Singh A, Bhaarat, Rainchwar S, Ahmed R, Bhurani D, Agrawal N. "An 'Uncommon early lineage switch' in an MLL rearranged adult B-lineage Acute Lymphoblastic Leukemia to Mixed-phenotypic acute leukemia (B/Myeloid)." International Journal of Clinical Images and Medical Reviews. 2022.
- Kapoor J, Mirgh SP, Agrawal N, Khushoo V, Tejwani N, Singh R, Mehta P, Bhurani D, Ahmed R. "High Risk Acute Promyelocytic Leukemia – An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol." (2022).
- Bhurani D, Schifter M, Kerridge I. "Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand." Bone Marrow Transplant. 2008 Oct; 42(8):547–50.
- Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S. "The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells." Haematologica. 2006.
- Srivastava A, Mathews V, Bhurani D, Baidya S, Chandy M. "Successful surgical hemostasis in patients with von Willebrand disease following infusion of Koate DVI." Thromb Haemost. 2002 Mar; 87(3):541–3.
- Bhurani D, Smith C, Thurlow P, Duggan J, Came N. Combined Annual Scientific Meeting of HSANZ, ANZSBT and ASTH. 2004.
Ongoing Research & Clinical Interests
- Bone marrow / stem cell transplantation (allogeneic, autologous, MUD, haplo)
- CAR-T cell therapy
- Acute leukaemia (AML, ALL, APML)
- Chronic myeloid leukaemia (Imatinib response)
- Lymphoma (Non-Hodgkin and Hodgkin)
- Multiple myeloma
- Myelodysplastic syndrome (Azacitidine treatment)
- Aplastic anaemia and thalassaemia transplants
- Coagulation disorders (Von Willebrand disease)
- Cytokine response in chemotherapy
- Bone marrow biopsy and immunostaining techniques
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematology / Bone Marrow Transplant Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Autologous Stem Cell Transplant | ₹10,00,000 – ₹16,00,000 | $12,000 – $19,200 |
| Allogeneic Stem Cell Transplant (Matched Sibling) | ₹18,00,000 – ₹28,00,000 | $21,600 – $33,600 |
| Haplo / MUD Stem Cell Transplant | ₹22,00,000 – ₹40,00,000 | $26,400 – $48,000 |
| CAR-T Cell Therapy | ₹40,00,000 – ₹1,00,00,000 | $48,000 – $1,20,000 |
| Acute Leukaemia Chemotherapy (per induction cycle) | ₹2,00,000 – ₹6,00,000 | $2,400 – $7,200 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Dinesh Bhurani use in Hematologist treatment?
Dr. Dinesh Bhurani uses advanced allogeneic stem cell transplant, modern autologous stem cell transplant, comprehensive matched unrelated donor (MUD) stem cell transplant, integrated haplo (half-matched) stem cell transplant, modern CAR-T cell therapy, comprehensive bone marrow aspiration and biopsy, integrated CD138 immunostaining for plasma cell disorders, modern bone marrow trephine specimen analysis, comprehensive acute leukaemia chemotherapy (induction, consolidation, maintenance), integrated lymphoma chemotherapy and targeted therapy, modern multiple myeloma chemotherapy and targeted therapy, comprehensive Imatinib and TKI therapy for CML, integrated azacitidine for MDS, modern blood transfusion and component therapy, plasmapheresis, lymphatic drainage, and immunotherapy — a pioneering toolkit refined through 1,500+ transplants and CMC Vellore plus 3+ years Australian training that establishes him as a leading hematologist specialist in New Delhi, India.
2. What conditions does Dr. Dinesh Bhurani specialize in treating?
Dr. Dinesh Bhurani specialises in acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML), lymphoma (Hodgkin and Non-Hodgkin), multiple myeloma, myelodysplastic syndrome (MDS), aplastic anaemia, thalassaemia major, sickle cell disease, chronic lymphocytic leukaemia (CLL), Von Willebrand disease, bleeding disorders and coagulopathies, bone marrow failure syndromes, myeloproliferative neoplasms, and cold agglutinin disease — comprehensive haemato-oncology and bone marrow transplant care for international patients seeking best bone marrow transplant in India.
3. How do I book an appointment with Dr. Dinesh Bhurani?
Appointments with Dr. Dinesh Bhurani can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Dinesh Bhurani?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Dinesh Bhurani, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Dinesh Bhurani offer second opinions for Hematologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert hematologist specialist in New Delhi, India, especially for complex acute leukaemia, lymphoma, multiple myeloma, bone marrow transplant candidate (allogeneic / autologous / MUD / haplo), CAR-T candidate, and aplastic anaemia / thalassaemia cases.

















